6-31272002-C-T

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2

The NM_002117.6(HLA-C):​c.70G>A​(p.Ala24Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,066,756 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0015 ( 1 hom., cov: 12)
Exomes 𝑓: 0.0013 ( 17 hom. )

Consequence

HLA-C
NM_002117.6 missense

Scores

1
2
14

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 0.109

Publications

5 publications found
Variant links:
Genes affected
HLA-C (HGNC:4933): (major histocompatibility complex, class I, C) HLA-C belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. About 6000 HLA-C alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005843401).
BP6
Variant 6-31272002-C-T is Benign according to our data. Variant chr6-31272002-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2656389.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 17 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002117.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-C
NM_002117.6
MANE Select
c.70G>Ap.Ala24Thr
missense
Exon 1 of 8NP_002108.4P10321-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HLA-C
ENST00000376228.10
TSL:6 MANE Select
c.70G>Ap.Ala24Thr
missense
Exon 1 of 8ENSP00000365402.5P10321-1
HLA-C
ENST00000383329.7
TSL:6
c.70G>Ap.Ala24Thr
missense
Exon 1 of 8ENSP00000372819.3A2AEA2
HLA-C
ENST00000956155.1
c.70G>Ap.Ala24Thr
missense
Exon 1 of 8ENSP00000626214.1

Frequencies

GnomAD3 genomes
AF:
0.00147
AC:
128
AN:
87254
Hom.:
1
Cov.:
12
show subpopulations
Gnomad AFR
AF:
0.000879
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00153
Gnomad ASJ
AF:
0.00921
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000802
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00435
Gnomad NFE
AF:
0.00174
Gnomad OTH
AF:
0.00178
GnomAD2 exomes
AF:
0.00219
AC:
535
AN:
244706
AF XY:
0.00218
show subpopulations
Gnomad AFR exome
AF:
0.00177
Gnomad AMR exome
AF:
0.00166
Gnomad ASJ exome
AF:
0.00985
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00112
Gnomad NFE exome
AF:
0.00264
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00127
AC:
1240
AN:
979438
Hom.:
17
Cov.:
25
AF XY:
0.00129
AC XY:
630
AN XY:
489458
show subpopulations
African (AFR)
AF:
0.00106
AC:
21
AN:
19786
American (AMR)
AF:
0.00162
AC:
44
AN:
27228
Ashkenazi Jewish (ASJ)
AF:
0.0115
AC:
183
AN:
15892
East Asian (EAS)
AF:
0.00
AC:
0
AN:
25590
South Asian (SAS)
AF:
0.00104
AC:
66
AN:
63638
European-Finnish (FIN)
AF:
0.000804
AC:
26
AN:
32324
Middle Eastern (MID)
AF:
0.00594
AC:
18
AN:
3028
European-Non Finnish (NFE)
AF:
0.00107
AC:
803
AN:
750578
Other (OTH)
AF:
0.00191
AC:
79
AN:
41374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00147
AC:
128
AN:
87318
Hom.:
1
Cov.:
12
AF XY:
0.00137
AC XY:
57
AN XY:
41676
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000875
AC:
18
AN:
20568
American (AMR)
AF:
0.00153
AC:
12
AN:
7866
Ashkenazi Jewish (ASJ)
AF:
0.00921
AC:
16
AN:
1738
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2466
South Asian (SAS)
AF:
0.000801
AC:
2
AN:
2498
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5922
Middle Eastern (MID)
AF:
0.00481
AC:
1
AN:
208
European-Non Finnish (NFE)
AF:
0.00174
AC:
77
AN:
44276
Other (OTH)
AF:
0.00177
AC:
2
AN:
1132
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000000000720202), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.398
Heterozygous variant carriers
0
7
13
20
26
33
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00428
Hom.:
1
ExAC
AF:
0.00294
AC:
355
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.029
T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.43
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.78
T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.0058
T
MetaSVM
Benign
-0.94
T
PhyloP100
0.11
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.12
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.0070
D
Polyphen
1.0
D
Vest4
0.30
MVP
0.21
MPC
0.50
ClinPred
0.095
T
GERP RS
3.2
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
gMVP
0.18
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs41553415; hg19: chr6-31239779; API